Aircules - Asthma

  • Study Sponsor and Protocol Number: 
    Sanofi DRI16762
  • Specialty:
    Pulmonology
  • Type:
    Investigational Drug
  • Inclusion:
    Age 18-80
    Moderate to severe asthma
    BMI 18.5-40
    2 documented asthma exacerbations in the last 12 months
  • Exclusion:
    Current Smoker
    Former smoker with a smoking history of greater than 10 pack year
    History of cancer

    •